An experimental drug just showed it can help slow Alzheimer's, offering new hope for patients and a major boost to pharma giant Eli Lilly

In a late-stage trial, Eli Lilly's experimental Alzheimer's treatment slowed the rate of cognitive decline in Alzheimer's patients by 35%.